Background: Chronic Obstructive Pulmonary Disease (COPD) was defined by the GOLD 2020 revision as a "common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities, usually caused by significant exposure to noxious particles or gases, and influenced by host factors including abnormal lung development" This study evaluated the use of DECAF score for prediction of mortality and need for IMV in patients admitted to ICU with AECOPD and also compared DECAF score with already existing BAP‑65 score. Methods: This comparative study included 50 patients who were admitted with COPD exacerbation from our ER to the ICU in Benha University hospitals. Results: The components of BAP 65 score compared between survivors and died patients was statistically significant difference was found in BUN >25 (21.43% in discharged group vs. 62.50% in died group, P = 0.018), Altered mental status (11.90% in discharged group vs. 50.00% in died group, P = 0.026) and pulse >109 bpm (21.43% in discharged group vs. 75.00% in died group, P = 0.002). Comparison in age >65 years between the two groups, was not found to be significant (40.48% in discharged group vs. 75.00% in died group, P = 0.073). The mean value of BAP 65 score was 2.19±1.04 in discharged group and 3.75±1.58 in died group with highly significant difference between groups (P= 0.001). Conclusions: COPD is a major health problem that affect patient health and life and represents a burden for the health services. COPD exacerbation is the cause of mortality in COPD patients, so early diagnosis and proper management improves the patient prognosis. Many factors affect the patient prognosis during AECOPD, it can be assessed by BAP65/DECAF scoring systems beside clinical judgment. |
